Status epilepticus

Current Neurology and Neuroscience Reports

Volumn 9, Issue 6, 2009, Pages 469-476

  Varelas, Panayiotis N ^a   Mirski, Marek A ^b  

^a HENRY FORD HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ANESTHETIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; DIAZEPAM; ETIRACETAM; GLUTAMATE RECEPTOR; GLYCOPROTEIN P; HARKOSERIDE; HYPERTENSIVE FACTOR; INOTROPIC AGENT; LORAZEPAM; MIDAZOLAM; N METHYL DEXTRO ASPARTIC ACID; PENTOBARBITAL; PHENOBARBITAL; PHENYTOIN; PLACEBO; PROPOFOL; PYRIDOXINE; TOPIRAMATE; VALPROIC ACID; VERAPAMIL;

ABSENCE; ADJUVANT THERAPY; ALCOHOL WITHDRAWAL; ANTICONVULSANT ACTIVITY; BRAIN TUMOR; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COMA; COMPLEX PARTIAL SEIZURE; DISEASE CLASSIFICATION; DRUG CLEARANCE; DRUG EFFICACY; DRUG HALF LIFE; DRUG TREATMENT FAILURE; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; FOCAL EPILEPSY; GRAND MAL SEIZURE; HEAD INJURY; HUMAN; HYPOTENSION; INCIDENCE; INTENSIVE CARE UNIT; LOADING DRUG DOSE; METABOLIC DISORDER; NEUROPATHOLOGY; REVIEW; RISK FACTOR; SEIZURE; STROKE; SUPRAVENTRICULAR TACHYCARDIA; THROMBOEMBOLISM; TONIC CLONIC SEIZURE;

ANTICONVULSANTS; ELECTROENCEPHALOGRAPHY; HUMANS; STATUS EPILEPTICUS;

EID: 70350153120     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-009-0069-7     Document Type: Review

References (56)

1. Kaplan PW: Assessing the outcomes in patients with nonconvulsive status epilepticus: Nonconvulsive status epilepticus is underdiagnosed, potentially overtreated, and confounded by comorbidity. J Clin Neurophysiol 1999, 16:341-352.
2. Towne AR, Pellock JM, Ko D, DeLorenzo RJ: Determinants of mortality in status epilepticus. Epilepsia 1994, 35:27-34.
3. Treiman DM, Meyers PD, Walton NY, et al.: A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998, 339:792-798.
4. DeLorenzo RJ, Towne AR, Pellock JM, Ko D: Status epilepticus in children, adults, and the elderly. Epilepsia 1992, 33(Suppl 4):S15-S25.
5. Legriel S, Mourvillier B, Bele N, et al.: Outcomes in 140 critically ill patients with status epilepticus. Intensive Care Med 2008, 34:476-480.
6. Gastaut H: Classification of status epilepticus. Adv Neurol 1983,34: 15-35.
7. Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. JAMA 1993, 270:854-859.
8. Millikan D, Rice B, Silbergleit R: Emergency treatment of status epilepticus: Current thinking. Emerg Med Clin North Am 2009, 27:101-113, ix.
9. Bleck TP: ConvulSive disorders: status epilepticus. Clin Neuropharmacol 1991, 14:191-198.
10. Lowenstein DH, Bleck T, Macdonald RL: It's time to revise the definition of status epilepticus. Epilepsia 1999, 40:120-122.
11. Lowenstein DH: The management of refractoryAstatus epilepticus: an update. Epilepsia 2006, 47(Suppl 1):35-40.
12. Walker MC: Diagnosis and treatment of nonconvulsive status epilepticus. CNS Drugs 2001, 15:931-939.
13. Hauser WA: StaEus epilepticus: epidemiologic considerations. Neurology 1990, 40:9-13.
14. DeLorenzo RJ, Hauser WA, Towne AR, et al.: A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996, 46:1029-1035.
15. Jordan KG: Nonconvulsive status epilepticus in acute brain injury. J Clin Neurophysiol 1999, 16: 332-340; discussion 53.
16. Towne AR, Waterhouse EJ, Boggs JG, et al.: Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology 2000, 54:340-345.
17. Claassen J, Jette N, Chum F, et al.: Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology 2007, 69:1356-1365.
18. Claassen J, Peery S, Kreiter KT, et al.: Predictors and clinical impact of epilepsy after subarachnoid hemorrhage. Neurology 2003, 60:208-214.
19. Cocito L, Audenino D, Primavera A: Altered mental state and nonconvulsive status epilepticus in patients with cancer. Arch Neurol 2001, 58:1310.
20. Vespa PM, Nuwer MR, Nenov V, et al.: Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoring. J Neurosurg 1999, 91:750-760.
21. Carrera E, Michel P, Despland PA, et al.: Continuous assessment of electrical epileptic activity in acute stroke. Neurology 2006, 67:99-104.
22. Mayer SA, Claassen J, Lokin J, et al.: Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 2002, 59:205-210.
23. Wijdicks EF, Sharbrough FW: New-onset seizures in critically ill patients. Neurology 1993, 43:1042-1044.
24. Bleck TP, Smith MC, Pierre-Louis SJ, et al.: Neurologic complications of critical medical illnesses. Crit Care Med 1993, 21:98-103.
25. Drislane FW, Lopez MR, Blum AS, Schomer DL: Detection and treatment of refractory status epilepticus in the intensive care unit. J Clin Neurophysiol 2008, 25:181-186.
26. Lowenstein DH, Alldredge BK: Status epilepticus. N Engl J Med 1998, 338:970-976.
27. Fountain NB: SRatus epilepticus: risk factors and complications. Epilepsia 2000, 41(Suppl 2):S23-S30.
28. Loscher W: Mechanisms of drug resistance in status epilepticus. Epilepsia 2007, 48(Suppl 8):74-77.
29. Bankstahl JP, Loscher W: Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus. Epilepsy Res 2008, 82:70-85.
30. Meldrum BS, Vigouroux RA, Brierley JB: Systemic factors and epileptic brain damage. Prolonged seizures in paralyzed, artificially ventilated baboons. Arch Neurol 1973, 29:82-87.
31. Aminoff MJ, Simon RP: Status epilepticus. Causes, clinical features and consequences in 98 patients. Am J Med 1980, 69:657-666.
32. DeLorenzo RJ, Waterhouse EJ, Towne AR, et al.: Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia 1998, 39:833-840.
33. Brenner RP: Is it status? Epilepsia 2002, 43(Suppl 3):103-113.
34. Kaplan PW: The EEG of status epilepticus. J Clin Neurophysiol 2006, 23:221-229.
35. Hirsch LJ, Claassen J, Mayer SA, Emerson RG: Stimulusinduced rhythmic, periodic, or ictal discharges (SIRPIDs): A common EEG phenomenon in the critically ill. Epilepsia 2004, 45:109-123.
36. Alldredge BK, Gelb AM, Isaacs SM, et al.: A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001, 345:631-637.
37. Agarwal P, Kumar N, Chandra R, et al.: Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure 2007, 16:527-532.
38. Schulze-Bonhage A, Kurthen M, Walger P, Elger CE: Pharmacorefractory status epilepticus due to low vitamin B6 levels during pregnancy. Epilepsia 2004, 45:81-84.
39. Iannetti P, Spalice A, Parisi P: Calcium-channel blocker verapamil administration in prolonged and refractory status epilepticus. Epilepsia 2005, 46:967-969.
40. Claassen J, Hirsch LJ, Emerson RG, Mayer SA: Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: A systematic review. Epilepsia 2002, 43:146-153.
41. Krishnamurthy KB, Drislane FW: Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus. Epilepsia 1999, 40:759-762.
42. Treiman DM: Convulsive status epilepticus. Curr Treat Options Neurol 1999, 1:359-369.
43. Krishnamurthy KB, Drislane FW: Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus. Epilepsia 1996, 37:863-867.
44. Rossetti AO, Logroscino G, Bromfield EB: Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol 2005, 62:1698-1702.
45. Rossetti AO, Bromfield EB: Determinants of success in the use of oral levetiracetam in status epilepticus. Epilepsy Behav 2006, 8:651-654.
46. Ruegg S, Naegelin Y, Hardmeier M, et al.: Intravenous levetiracetam: treatment experience with the first 50 critically ill patients. Epilepsy Behav 2008, 12:477-480.
47. Knake S, Gruener J, Hattemer K, et al.: Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus. J Neurol Neurosurg Psychiatry 2008, 79:588-589.
48. Kellinghaus C, Berning S, Besselmann M: Intravenous lacosamide as successful treatment for nonconvulsive status epilepticus after failure of first-line therapy. Epilepsy Behav 2009, 14:429-431.
49. Towne AR, Garnett LK, Waterhouse EJ, et al.: The use of topiramate in refractory status epilepticus. Neurology 2003, 60:332-334.
50. Corry JJ, Dhar R, Murphy T, Diringer MN: Hypothermia for refractory status epilepticus. Neurocrit Care 2008, 9:189-197.
51. Varelas PN: How I treat status epilepticus in the Neuro-ICU. Neurocrit Care 2008, 9:153-157.
52. Ziai WC, Kaplan PW: Seizures and status epilepticus in the intensive care unit. Semin Neurol 2008, 28:668-681.
53. Robakis TK, Hirsch LJ: Literature review, case report, and expert discussion of prolonged refractory status epilepticus. Neurocrit Care 2006, 4:35-46.
54. Rossetti AO, Oddo M, Liaudet L, Kaplan PW: Predictors of awakening from postanoxic status epilepticus after therapeutic hypothermia. Neurology 2009, 72:744-749.
55. Hesdorffer DC, Logroscino G, Cascino GD, Hauser WA: Recurrence of afebrile status epilepticus in a population-based study in Rochester, Minnesota. Neurology 2007, 69:73-78.
56. Varelas PN, Mirski MA: Seizures in the adult intensive care unit. J Neurosurg Anesthesiol 2001, 13:163-175.